Spinal cord injury and regeneration involves transcriptional activity of many genes, of which many remain unknown. Using the rat spinal cord fulltransection model, bioinformatics, cloning, expression assays, fusion proteins, and transfection techniques, we identified and characterized one such differentially expressed gene, termed scirr1 (spinal cord injury and/or regeneration related gene 1). Fourteen orthologs were found in 13 species from echinoderm to insect and human by Blast search of NCBI protein reference sequence database. However, no further information is available for these homologues. Using whole-mount in situ hybridization, mouse scirr1 mRNA was expressed temporally and spatially in accordance with the early development sequence of the central nervous system. In adult rat spinal cord, expression of scirr1 mRNA was localized to neurons of gray matter by in situ hybridization. Using immunohistochemistry, SCIRR1 protein was found to be up-regulated and expressed more highly in spinal cord neurons farther from the epicenter of injury. Although the precise function of SCIRR1 is unknown, its unique pattern of expression during CNS early development and up-regulation after spinal cord injury suggest that SCIRR1 should be involved in the succeeding injury and/or repair processes of the injured spinal cord. Also, the typical F-box and leucine-rich repeat (LRR) architecture of rat SCIRR1 indicated that it may play an important substrate recruiting role in the pleiotropic ubiquitin/ proteasome pathway. All these make scirr1 a new interesting start to study the spinal cord injury and regeneration mechanism.
Introduction
At present, there is no universally accepted treatment for paraplegia caused by injury to the spinal cord, mainly because of the indetermination of many genes believed to be involved in the complex pathophysiology of spinal cord injury and repair (Beattie et al., 2002; Profyris et al., 2004) . Genes serving to repair injured spinal cord have been shown to reach their expression peaks 3.5 to 5 days post injury (Hayashi et al., 2000) . To identify more genes, especially new ones, underlying the processes after the injury of spinal cord, we made a complete transection model of rat spinal cord and performed an improved subtractive hybridization (Zhao et al., 1999) from cDNA of spinal cord post-transection day 4.5 against that of intact spinal cord as a means of identifying up-regulated genes in the injury and/or regeneration process. A total of forty validated highquality expressed sequence tags (EST) were successfully sequenced. Bioinformatics analysis revealed that eight of these sequences represent novelgenes, which clearly reveals our current deficiency in the understanding of the subsequent processes after spinal cord injury (Ma et al., 2006) . It further indicates that we need to continue our investigation into the nature of these functionally uncharacterized new genes, which will enable us to identify potential regulatory genes of spinal cord injury and repair. Our laboratory recently embarked on this laborious task, and we present our ndings for one such novel gene, termed scirr1 (spinal cord injury and/or regeneration related gene 1).
To infer the potential role of scirr1 in the processes after spinal cord injury, we introduce data dealIdentification and characterization of scirr1, a novel gene up-regulated after spinal cord injury ing with the molecular cloning and characterization of scirr1, which include scirr1 expression profiles in different developmental stages, and after transection of the adult rat spinal cord. In addition, domain architecture was analyzed to deduce the possible pathway through which SCIRR1 takes its function.
Materials and Methods

Animals
We studied adult male Wistar rats weighing between 220-250 g, housed in plastic sawdust-covered cages with a normal light/dark cycle and free access to rat chow and water. All protocols were reviewed and approved by Beijing Institute of Basic Medical Sciences using the European Communities Council Directive of 24 November 1986 (86/609/EEC). Experiments were designed to minimize the number of animals required and to minimize animal suffering. Rats were anesthetized with pentobarbital (60 mg/kg) prior to all procedures.
Spinal cord full-transection model
Adult male Wistar rats, weighing between 220-250 g and at the same age, were anesthetized with sodium pentobarbital (60 mg/kg). A ∼1.8-cm dorsal median incision was made over the thoracic vertebral column. The vertebral arch and the spinous processes of T8-10 were exposed by cutting the caudal part of the nuchal ligament and separating the underlying sacrospinous muscle from its origin of the spinal processes. The medial part of the autochthone musculature was retracted to the side over two segments from the spinal processes and the arches of the vertebra. Exposed by laminectomy, the cord at the T9-10 level was then transected completely with a self-made scalpel (8 mm blade depth, 15 o ) in one movement from the right to the left. The autochthone muscles and the sacrospinous muscles of both sides were repositioned and gently opposed by three single sutures using 10-0 nylon thread. With the same suture, the skin was closed. Animals were kept individually and permitted survival for 1, 3, 4.5 and 5 days respectively. Sham-operated rats, receiving all operations but with only the transection of spinal cord and dorsal spinal vein, served as controls.
Bioinformatics analysis and cloning of scirr1 coding sequence (CDS) The original EST sequence (GenBank Accession no. CV463503) of scirr1 was mapped to chromosome 10q12. The genomic DNA sequence between its flanking genes was chosen for CDS prediction by the GenScan (Burge and Karlin, 1997) and HMMgene (Krogh, 1997) web servers. The primers were designed using the predicted CDS sequence as template. Total RNA of post-transection day 4.5 rat spinal cord was harvested from a 5-mm segment of spinal cord centered on the point of transection, using the SV Total RNA Isolation System and protocol (Promega, Madison, NJ). First strand cDNA was synthesized with the SuperScript II RNaseH Reverse Transcriptase (Invitrogen, Carlsbad, CA). A PCR reaction was carried out with first strand cDNA and the primers (5'-ATGTCGAGCCCTGGTATC-3' and 5'-CTA-TTCAATGACGAGGCAG-3') using the following PCR conditions: 60 o C for 30 min, 94 o C for 2 min, and 40 cycles of 94 o C for 30 s, 65 o C for 1 min, and 72 o C for 1 min. The PCR product was subcloned into the pGEM-T vector (Promega, Madison, NJ) and sequenced.
RT-PCR analysis of scirr1 mRNA expression RNA was harvested respectively from various fresh rat tissues (skeletal muscle, heart, liver, thymus, spleen, pancreas, kidney, stomach, lung, small intestine, large intestine, testis, cerebra, cerebellum, brain stem and spinal cord) using the SV Total RNA Isolation System and protocol (Promega, Madison, NJ). First strand cDNA synthesis was carried out with the SuperScript II RNaseH Reverse Transcriptase (Invitrogen, Carlsbad, CA) in a volume of 50 l using 2 g of RNA and 125 ng of Oligo (dT)15. PCR reaction was then carried out with 2 l of first strand cDNA and the set of scirr1-specific primers (5'-GTCGCAAACTTCTCATGGCTAA-3' and 5'-TCGTG-CTGGACAGGTGTGTAC-3'). GAPDH was amplified as a control marker with primers (5'-TCCCTCAA-GATTGTCAGCAA-3' and 5'-AGATCCACAACGGAT-ACATT-3'). PCR products were separated by 1.2% agarose gel electrophoresis.
Preparation of scirr1 RNA probe Blast search against the rat mRNA database of GenBank revealed that the 147 bp fragment from nucleotides 1,130 to 1,276 is the most specific sequence of the rat scirr1 coding region. This fragment covers the 3' part of the third exon and the 5' part of the fourth exon, which enables probe derived from this fragment to identify scirr1 mRNA specifically. Then this fragment was amplified using primers 5'-CTGGAATTCGTCGCAAACTTCTCATGGCTAA-3' and 5'-TACAAGCTTTCGTGCTGGACAGGTGTGTAC-3', and the PCR product was inserted into the pSPT19 vector (Roche, Grenzacherstrasse, Basel, Switzerland) between the EcoRI and HindIII sites. Following verification by DNA sequencing, vectors were linearized by EcoRI and HindIII respectively for sense and antisense digoxigenin-labeled riboprobes synthesis by in vitro transcription using the DIG RNA labeling kit (SP6/T7) and protocol (Roche, Grenzacherstrasse, Basel, Switzerland).
In situ hybridization histochemistry Adult male Wistar rats, weighing between 220 and 250 g, were anesthetized with sodium pentobarbital (60 mg/kg), perfused through the left atrium with physiological saline weighing twice the rat's weight, and then perfusion-fixed using the same volume of 4% paraformaldehyde fixative. The spinal cord was taken out, immersion-fixed in 4% paraformaldehyde at 4 o C for 4 h, and washed with PBS 4-5 times for 1 h. After immersion at 4 o C in 30% sucrose for inhibition of ice crystal formation, the tissues were embedded in optimum cutting temperature (OCT) compound and were frozen in liquid nitrogen. Then 30-m frozen coronal sections were cut on a CRYO-CUT II microtome (American Optical Corp., Buffalo, NY). After washing 3 times with PBS and treatment with 0.1 M glycin in PBS for 5 min, the sections were put in PBS containing 0.3% TritonX-100 for 30 min. Sections were moved into 1 g/ml proteinase K for 5 min and then immersion-fixed with 4% paraformaldehyde for 10 min. Following 3 washes with PBS, the tissues were acetylated with 0.25% acetic anhydride for 10 min and sequentially treated with double strength standard saline citrate (2×SSC, 1×SSC = 0.15 M NaCl, 15 mM sodium citrate, pH7.0) for 10 min. Then the sections were incubated in prehybridization solution (5×SSC, 50% formamide, 0.1% Tween 20, 50 g/ml heparin, and 100 g/ml sonicated and denatured salmon sperm DNA) for 4 h at 42 o C. With the prehybridization solution removed, the sections were incubated with fresh hybridization buffer containing 0.5 g/ml digoxigenin-labeled RNA probe at 55 o C in a humid atmosphere for 16 h. Then sections were washed in 2×SSC at room temperature for 30 min, in 1×SSC for 10 min, and in 0.1×SSC for 10 min. Detection of the probe in the sections was carried out using the DIG nucleic acid detection kit (Roche, Grenzacherstrasse, Basel, Switzerland) basically according to the manufacturer's instructions. Sections incubated with digoxigenin-labeled RNA probe were rinsed 3 times briefly in a washing buffer (0.1 M Maleic acid, 0.15 M NaCl, pH 7.5, 0.3% (v/v) Tween 20), incubated with a blocking solution (1% (w/v) Roche blocking reagent in washing buffer) for 30 min, incubated with a 5000× dilution of anti-digoxigenin-AP in blocking solution for 3.5 h, washed with washing buffer two times for 15 min, and finally equilibrated 5 min in a detection buffer (0.1 M Tris-HCl, 0.1 M NaCl, pH 9.5). Then the sections were incubated in darkness with 2% (v/v) nitro blue tetrazolium and 5-bro-Whole-mount in situ hybridization histochemistry To determine the embryonic expression of scirr1 mRNA, whole-mount in situ hybridization was carried out on KM mouse embryos, obtained by timed matings, with noon of the day of the vaginal plug designated as 0.5 days post-coitum (dpc). The pregnant females were killed by cervical dislocation on 9-13 dpc and the uteri were washed in ice-cold PBS. The embryos were dissected free in 4% paraformaldehyde/PBS, and fixed in this solution overnight at 4 o C. Embryos were rocked gently at room temperature throughout the procedure on a mechanical rocking platform unless otherwise indicated. The embryos were washed three times with PBS containing 0.1% (v/v) Tween 20 (PBT), dehydrated into 100% methanol and stored at -20 o C. To resume, the embryos were treated with 5:1 methanol/30% hydrogen peroxide for 3 to 5 h. After several washes with methanol, the embryos were rehydrated through a methanol-PBT series and washed three times in PBT. Embryos were treated with 10 g/ml proteinase K in PBT for 25 min, followed by washing for 10 min with PBT. The embryos were refixed in 0.1% glutaraldehyde and 4% paraformaldehyde in PBS for 20 min and then washed two times with PBT each for 10 min. The samples were dipped in hybridization buffer (5×SSC, 50% (v/v) formamide, 0.1% (v/v) Tween 20, 50 g/ml heparin, 100 g/ml yeast tRNA and 100 g/ml denatured salmon sperm DNA) for two hours at 63 o C. Then hybridization was carried out with 0.5 g/ml digoxigenin-labeled riboprobes in fresh hybridization buffer at 63 o C for 18 h. After four 15-min washes with 50% (v/v) formamide in 2×SSC at 63 o C, samples were rinsed with RNase buffer (0.5 M NaCl, 10 mM Tris-HCl (pH 7.6), 1 mM EDTA) twice, and then incubated with 20 g/ml RNase A and 100 U/ml RNase T1 in RNase buffer at 37 o C for 20 min. Subsequently, samples were rinsed with 1% (v/v) Tween 20 in 2×SSC 4 times for 15 min each at 63 o C, and then with 1% (v/v) Tween 20 in 1×SSC 4 times for 15 min each at 63 o C. The embryos were treated with buffer I (100 mM Tris-HCl (pH 7.5), 150 mM NaCl) for 15 min, washed with 5% BSA and 0.1% (v/v) Tween 20 in buffer II (137 mM NaCl, 25 mM Tris-HCl pH 7.5, 3 mM KCl) for 4 h, incubated with 2,000× diluted anti-digoxigenin-AP (Roche, Grenzacherstrasse, Basel, Switzerland), 5% BSA and 0.1% (v/v) TritonX-100 in buffer II at 4 o C overnight, washed with 0.1% TritonX-100 in buffer I four times for 1 h each, and then equilibrated by four 15-min washes with 2 mM levamisole in buffer III (100 mM Tris-HCl (pH 9.5), 100 mM NaCl, 50 mM MgCl2). Finally, the embryos were incubated with 2% (v/v) NBT/BCIP in buffer III for color development. When staining was satisfactory, the embryos were washed twice with sterile double distilled water. After dehydration and background elimination with graded formamide, embryos were cleared in 100% glycerol. With strong transillumination, embryos were observed and photographed using an Olympus SZX9 dissecting stereo microscope and PM-C35DX camera.
Generation of enhanced green fluorescent protein (EGFP) fusion
To assess SCIRR1 protein localization, a SCIRR1-EGFP fusion protein was constructed. Primers (5'-CTCAAGCTTAGCATGTCGAGCCCTGGTATCGA-3' and 5'-GTGGGATCCGGTTCAATGACGAGGCAG-3') containing unique 5' HindIII and 3' BamHI restriction sites were designed and used to amplify the complete SCIRR1 coding region except for the stop codon. The amplified fragment was restriction digested and ligated into the pEGFP-N1 vector (Clontech, CA), which is under the control of the CMV promoter and leads to the generation of a fusion protein with SCIRR1 fused to the amino terminus of EGFP. Potential SCIRR1-EGFP plasmids were isolated from transformed cells and screened for the presence of the scirr1 cDNA insert by PCR. The correct (5'-3') orientation and frame of the scirr1 insertion were then verified by sequencing. Bacterial stock solutions containing the verified SCIRR1-EGFP plasmid were used to isolate SCIRR1-EGFP plasmid DNA for the subsequent transfection experiments.
Cell culture and transfection
Transient transfection studies were performed using PC12 cells maintained in the log growth phase. Cells were plated in standard 6-well tissue culture plates containing glass coverslips at an initial density of 1 ×10 5 cells/well and transfected with SCIRR1-EGFP plasmid, facilitated by the addition of the transfection reagent Lipofectamine 2000 (Invitrogen, Carlsbad, CA). As a negative control, transfections were carried out in the same manner, using the parental pEGFP-N1 vector. After 48 h, cells were washed, fixed in 4% paraformaldehyde, mounted, and imaged with epi-fluorescence confocal microscopy (Bio-Rad Radience 2100) at the National Center of Biomedical Analysis.
Preparation of antiserum against purified SCIRR1
The whole coding sequence of scirr1 was amplified using a forward primer including the BamHI site (underlined), 5'-CGTGGATCCATGTCGAGCCCTGG-TATC-3', and a reverse primer including the XhoI site, 5'-CAGCTCGAGCTATTCAATGACGAGGCAG-3'. The amplified fragment was digested with BamHI and XhoI and subcloned into pGEX-4T-2 (Amersham Biosciences, Piscataway, NJ), an N-terminal glutathione S-transferase (GST) fusion vector. A transformant of Escherichia coli BL21 (DE3) was cultured to A600 = 0.7 at 37 o C and maintained in 0.5 mM isopropyl-D-thiogalactopyranoside at 25 o C for 20 h. The cells were sonicated and centrifuged, and then the supernatant was applied to a GSTrap FF 1 ml column (Amersham Biosciences, Piscataway, NJ). Consequently, the expressed GST fusion protein, which contains a thrombin protease site between the GST and SCIRR1 sequence, was captured on the column. After washing impurities, the fusion protein was incubated on a column with thrombin (20 U/ml in 1×PBS) for 16 h at 24 o C. Then the target SCIRR1 protein minus the GST moiety was eluted using 1×PBS and condensed using an Amicon Ultra-4 centrifugal filter unit. Intact GST fusion protein was not detected in the purified SCIRR1 solution by SDS-PAGE. The purified SCIRR1 protein (500 g) was injected hypodermically into a rabbit in Freund's complete adjuvant. After three boosters of the purified SCIRR1 (125 g) in Freund's incomplete adjuvant at 2-week intervals, the anti-SCIRR1 serum was obtained ten days after the last injection. The specificity of antiserum for SCIRR1 was verified by Western blot assay of the purified SCIRR1 and total protein derived from rat spinal cord at 4.5 days post-transection.
Western blot analysis
Proteins in the samples were separated by SDS-PAGE and electrotransferred onto nitrocellulose membrane. Then the membrane was briefly rinsed in a buffer containing 25 mM Tris HCl, pH 7.4, 150 mM NaCl, 3 mM KCl, and 0.02% (v/v) Tween-20 (TTBS). The membrane was incubated at room temperature for 1 h in TTBS containing 5% (w/v) skim milk powder to block nonspecific binding of antibodies and then rinsed three times for 5 min each in TTBS. Then the membrane was probed with rabbit anti-SCIRR1 serum or together with GAPDH antibody (Santa Cruz, CA) in TTBS containing 1% (w/v) skim milk powder for 1.5 h at room temperature, followed by three to five 10-min washes with TTBS alone. Membrane was then incubated for 1 h with the HRP-conjunct sheep anti-rabbit secondary antibody also diluted in TTBS containing 1% (w/v) skim milk powder, followed by three to five 5-min washes with TTBS. After the final wash, immunoreactive proteins were detected by the enhanced chemiluminescence system (ECL, Amersham Pharmacia) and serial exposures were made to x-ray film (X-Omat BT Film; Kodak).
Immunohistochemistry
With the same procedure described in 'in situ hybridization histochemistry', 30-m frozen coronal sections at the T11 and L2 levels were prepared from the sham-operated rats and injured rats at days 1, 3 and 5 post full-transection of spinal cord. After washing 3 times with PBS and treatment with 0.1 M glycin in PBS for 5 min, the sections were put in PBS containing 0.3% TritonX-100 for 30 min. Rabbit anti-SCIRR1 polyclonal antibodies were incubated on frozen sections (10 m) at 4 o C overnight. Finally, the sections were rinsed with tap water, mounted, dehydrated, viewed with an Olympus BX50 microscope, and photographed using a digital camera (Olympus C7070). The signal was detected by chemiluminescence.
Results
scirr1 encodes a novel F-box and leucine-rich repeat protein
Blasting against the rat genome sequence, the original EST sequence (GenBank Accession no. CV-463503) of scirr1 was mapped to chromosome 10q12. Sequence around the EST sequence was analyzed by the GenScan (Burge and Karlin, 1997) and HMMgene (Krogh, 1997) web servers, both giving the same prediction of a coding region spanning the EST sequence. So we designed primers based on the predicted 1440 bp CDS sequence and subcloned the expected fragment ( Figure 1A ) from post-transection day 4.5 rat spinal cord RNA. After verification by DNA sequencing, the sequence ( Figure  1B ) was deposited at GenBank under the accession number NM 001009504. Then the translated 479 aa protein sequence of SCIRR1 was used to blast against the NCBI protein reference sequence database searching for homologous proteins. Our BLAST search resulted in 14 ortholog proteins (Table 1) which were conserved in 13 species from echinoderm to insect and human with homology levels varied from 70% (Strongylocentrotus purpuratus and Apis mellifera) to 99% (Mus musculus). Although 11 of them were proteins predicted by automated com- putational analysis, their fast minimum evolution tree ( Figure 1D ), constructed by the Blast Tree View Widget at NCBI, accorded with the currently accepted evolution of species.
To predict its function, the amino acid sequence of SCIRR1 was subjected to the InterPro motif analysis web server (http://www.ebi.ac.uk/InterProScan/). SCI-RR1 was found to bear an F-box signature (aa 94-139) in the N terminal region and seven Leucine-rich repeat (LRR) motifs (aa 241-266, 267-291, 293-318, 319-344, 345-370, 371-396 and 421-446) in the C terminal region ( Figure 1C) , which is one of the typical motif architectures of the substrate adaptors in SCF (SKP1-CULLIN-F-box) E3 ubiquitin ligase complexes.
scirr1 mRNA is widely expressed in adult tissues Since scirr1 represented a novel gene, we sought to determine its distribution in adult tissues. We extracted RNA from various organs, including skeletal muscle, heart, liver, thymus, spleen, pancreas, kidney, stomach, lung, small intestine, large intestine, testis, cerebra, cerebellum, brain stem and spinal cord, and performed RT-PCR analysis. Results from this experiment revealed wide expression throughout various types of tissue except for thymus ( Figure  2A ).
In spinal cord, scirr1 mRNA is expressed in gray matter neurons Is scirr1 expressed also ubiquitously in spinal cord? To reveal the cellular origin(s) of scirr1 mRNA in the spinal cord, in situ hybridization was used in conjunction with antisense riboprobes and sections derived from the T10 segment of intact rat spinal cord. scirr1 expression in spinal cord is localized in the gray matter ( Figure 2B ). At higher magnification it is evident that these scirr1-expressing cells are neurons, especially the large motor neurons in the ninth layer ( Figure 2C ). scirr1 mRNA is specifically expressed and developmentally regulated in CNS during embryonic stages Since repair is essentially a recapitulation of development, we wanted to determine whether and how scirr1 is expressed during embryonic nervous system development. To address this, we performed whole-mount in situ hybridization on mouse embryos of E9.5, E10, E10.5, E11.5, E12 and E13 (Figure 3) . The results clearly revealed its specific expression in the central nervous system during the stages of E10-E13. scirr1 expression was detected initially in ventral aspects of telencephalon at the E10 stage.
During the stages of E11.5-E12, the positive stain dispersed to a wider area of the forebrain, while strong expression was concentrated in the ventral parts of the midbrain and hindbrain. At the E13 stage, the stain was detected spreading throughout all of the brain areas at a further reduced density, while expression was first seen in ventral aspects of the spinal cord (indicated by a black arrowhead). A sense probe was applied on an E12 embryo as background control and no expression was detected. So, scirr1 mRNA emerged in ventral parts of telencephalon, midbrain, hindbrain and spinal cord sequentially, in accordance with their development sequence. And then in each brain area, along with development, expression of scirr1 arose gradually in increasingly wider area.
Rabbit anti-SCIRR1 serum binds SCIRR1 with high specificity Antibody is needed to invest protein expression characteristics of SCIRR1. Using the recombinant pGEX-4T-2 vector encoding GST-SCIRR1 fusion protein, we obtained the fusion protein from E. coli BL21. Following removal of the GST tag by thrombin, the purified SCIRR1 protein was used as antigen for rabbit anti-SCIRR1 serum preparation. Using the prepared rabbit anti-SCIRR1 serum, only one single positive band, representing the same molecular weight as SCIRR1 (about 51.8 KDa), was detected in Western blot assay of either the purified SCIRR1 protein or the total protein extracted from post-transection day 4.5 rat spinal cord (Figure 4 ). So we successfully obtained an antiserum that is highly specific for SCIRR1.
SCIRR1 is located in cytoplasm
To get a first insight in the cellular function of SCIRR1, we established its subcellular localization. Transient transfections with the SCIRR1-EGFP construct and parental pEGFP-N1 plasmids were carried out in PC12 cells. The cytoplasm of cells transfected with SCIRR1-EGFP was labeled exclusively, indicating the capture of SCIRR1-EGFP fusion protein in cytoplasm ( Figure 5A ). Transfection with the parental vector resulted in diffuse labeling throughout the cells, demonstrating active EGFP translation with no specific subcellular localization ( Figure 5B ).
To further determine its location in primary neurons, immunohistochemical assay was performed on rat spinal cord section with the previously prepared anti-SCIRR1 serum. Similar to the location of SCIRR1-EGFP in PC12 cells, the positive stain was only found in cytoplasm and processes ( Figure 5C , D).
Spatial and temporal variation of SCIRR1 protein in spinal cord after injury To infer its possible role in spinal cord injury and/or regeneration, we set to determine the spatial and temporal variation of SCIRR1 in neurons at particular sections of injured spinal cord. To address this, Figure 3 . Expression of scirr1 in mouse embryo by whole-mount in situ hybridization, using digoxigenin-labeled scirr1 riboprobes on mouse embryos at different stages of development from E9.5 to E13. scirr1 expression was detected initially in ventral aspects of telencephalon at stage of E10. During stages of E11.5-E12, the stain dispersed widely in forebrain, while strong expression was detected in the ventral parts of midbrain and hindbrain. At stage of E12, much stronger stain was found in telencephalon, midbrain and hindbrain. At stage of E13, the stain was detected throughout the whole brain areas in a reduced density, while expression was first seen in ventral aspects of the spinal cord (black arrowhead). t, telencephalon; m, mesencephalon; r, rhombencephalon. A sense probe was applied on an E12 embryo as background control. Bar of E9.5 is 0.5 mm. Bars of other stages are all 1 mm. Figure 4 . Verification of the specificity of rabbit anti-SCIRR1 serum by Western analysis. SCIRR1, the purified SCIRR1 protein with calculated molecular weight about 51.8 KDa. PI4.5, the total protein extracted from post-transection day 4.5 rat spinal cord. The single positive band detected in lane PI4.5 indicated rabbit anti-SCIRR1 serum recognizes SCIRR1 specifically.
we performed an immunohistochemical assay on rat spinal cord T11 (Figure 6A-D) and L2 ( Figure 6E -H) sections derived respectively from intact ( Figure 6A , E) and post-transection spinal cord at days 1 ( Figure  6B, F), 3 (Figure 6C , G) and 5 ( Figure 6D, H) . SCIRR1 was up-regulated in most neurons at both T11 and L2 sections obviously after transection injury, reaching its expression peak 3 days later.
Interestingly, the positive stain in most of the neurons at the L2 section was much deeper than that at the T11 section at the same time post injury.
Considering the lighter positive stain in most of the neurons at the L2 normal control section than that at the T11 normal control section, the relative expression of SCIRR1 should be stronger in most neurons at L2 section than in that at T11 section at the same time post injury.
Discussion
In a previous study, we identified a novel rat EST sequence up-regulated after transection trauma of spinal cord (Ma et al., 2006) . And the present study was designed to try to identify its full coding sequence and make a general characterization in context of CNS and spinal cord, which will provide useful clues for further study on its role in spinal cord injury and/or regeneration process.
Aided by bioinformatics, we successfully predicted and cloned the full CDS sequence of the scirr1 gene. Homology analysis revealed that there were 14 homologues conserved from echinoderm to insect and human (Table 1 and Figure 1D ). This indicates that scirr1 may function in some basic cellular processes. Among these homologues, 11 were predicted by automatic computer analysis. Except for the sequences, there is presently no other information of these homologues available. So this study gives the first report of this gene's biological characters.
As expression profile and its variations under different circumstances should be informative to deduce the possible role of a new gene, we examined scirr1's tissue distribution, cellular expression, intracellular expression, developmental expression and expression modification after spinal cord injury. As seen in Figure 3 , scirr1 mRNA emerged in telencephalon, midbrain, hindbrain and spinal cord sequentially accompanying their initial development, and then spreading to an increasingly wider area in each brain area along with the early development period. In view of its expression in adult neurons instead of glial cells ( Figure 2B and C), this developmentally regulated expression profile indicate that scirr1 may be expressed in neural precursor cells which migrate to progressively broader area differentiating into neurons, along with the same migration of much more amount glial cells originated from neuroepithelial cells. Further, SCIRR1 protein was found to be up-regulated in a distance-to-injury related manner in response to full transection of spinal cord (Figure 6 ). At the same time post injury, the more distance away from the injury site, the stronger up-regulation of SCIRR1 protein was found. This distance-to-injury related manner should be induced by distinctive environments around the examined T11 and L2 sections. It is well-known that changes in gene expression in the neurons distal to the injury site could reflect not only the regeneration response but also inflammatory and neuroprotective responses by diffusible signals from the injury site or by loss of synaptic input. In recent years, many investigators have observed the characteristic inflammatory response that emerged robustly at the injury site and spread to the distal cord in a lower level (Carmel et al., 2001; Aimone et al., 2004; De Biase et al., 2005) . L2 section is farther from the transected section (between T9 and T10) than the T11 one. So L2 section should have weaker inflammatory and neuroprotective responses than the T11 section. If up-regulation of SCIRR1 is induced by inflammatory and neuroprotective responses, the positive stain in the neurons at L2 section should be much lighter than that at the T11 section at the same time post injury, which is opposed to what we have observed. On the other hand, regeneration response is usually postponed by injury reaction in nerve system. As observed by Velardo et al. (2004) tissue repair transcripts were up-regulated dramatically only by 3 days post injury of spinal cord. Genes associated with putative regenerative responses in the Figure 6 . Immunohistochemical analysis of altered expression of SCIRR1 protein in rat spinal cord neurons after full-transection injury, using selfmade rabbit anti-SCIRR1 serum. A, E, normal control; B, F, 1 day post-injury; C, G, 3 days post-injury; D, H, 5 days post-injury. Expression of SCIRR1 protein in most neurons were enhanced after injury and reached its peak 3 days post-injury at spinal cord levels of T11 (A-D) and L2 (E-H). At 5 days post-injury, SCIRR1 were downregulated slightly in comparison with the early days. Compared to that in the corresponding normal control, the relative expression of SCIRR1 protein was found, at the same time post injury, to be stronger in most of the neurons at section L2 than in those at section T11. The area of the black boxes are enlarged and shown in the immediate bottom panels respectively, which show alteration of SCIRR1 protein expression in the neurons.
spinal cord, such as phosphodiesterase 4, nestin, glia-derived neurite promoting factor and growth associated protein 43, were found to increase significantly in a higher level and earlier stage in the distal segment than in the injury site (Carmel et al., 2001; Grossman et al., 2001 ). T11 section is much closer to the injured site, so regeneration response here should occur later than L2 section. If up-regulation of SCIRR1 is involved in regeneration, the extent of incensement in neurons at L2 section should be much larger than that one at T11 section, which is in harmonic with the experimental results. Together with its highest expression at day 3 after injury and the developmentally modulated specific expression pattern in CNS, there is much more possibility for SCIRR1 to take regeneration related role in the subsequent processes following spinal cord injury, although direct evidence is needed.
Interestingly, scirr1 mRNA was found to be expressed in various adult tissues (Figure 2A ). In view of its developmentally regulated specific expression in early embryonic CNS, this may suggest that scirr1 functions in an extraordinary molecular mechanism that is basic for adult tissues but very important for CNS development exclusively.
To explore its possible molecular functional mechanism, SCIRR1 protein sequence was subjected to motif analysis. And the result revealed that SCIRR1 possesses the typical motif architectures of the substrate adaptors in SCF E3 ubiquitin ligase complexes, indicating that SCIRR1 may be a new substrate adaptor that recruits substrates for ubiquitination by the SCF complex. The ubiquitinated substrates are then transferred to 26S proteasome for degradation. This modification and degradation system, named the ubiquitin/proteasome system, is a crucial determinant of virtually all biological processes in eukaryotes, exerting controls over stability of numerous regulators including cell cycle proteins (e.g., cyclins, CDK inhibitors and replication factors), transcription factors (e.g., I B and -catenin), tumor suppressor proteins (e.g., Rb and p53), oncoproteins (e.g., Myc and Jun), membrane proteins (e.g., growth factor receptors) and many more (Willems et al., 2004) . Moreover, the ubiquitin/proteasome system has been found to be required for neuronal pathfinding during development, regulation of synaptic branching and number, and synaptic plasticity (Johnston and Madura, 2004) .
Substrate adaptors of SCF can be classified into three major classes, of which one is FBXL with a typical F-box and multiple LRRs architecture (Jin et al., 2004) . Up to now, including SCIRR1, there were totally 22 members of FBXL reported (Jin et al., 2004) . And only 4 members have been characterized: SKP2/FBXL1 is restricted in nuclei and promotes cell cycle procession during S and G2 phases (Zhang et al., 1995; Lisztwan et al., 1998; Yu et al., 1998) ; FBXL2 is located in the cytosol around nuclei and function in the maintenance of cell growth-arrest (Ilyin et al., 1999) ; FBXL3 is expressed specifically in brain and testis (Ilyin et al., 2000) ; and FBXL13 is characterized as candidate myeloid tumor suppressor (Curtiss et al., 2005) . So, despite the structural homology, FBXLs likely target different proteins and consequently play distinct roles as argued by their distinctive expression pattern. And the structural basis of functional divergences is mainly ascribed to their distinctive LRRs domains (Willems et al., 2004) . Since different adaptors recognize distinct substrates, the discovery of scirr1 may suggest an expansion of substrates and subsequently pathways regulated by the ubiquitin/proteasome system. Except for SKP2 and FBXL2, SCIRR1 is the third FBXL to have intracellular location addressed by experimental method. Recently, many genes involved in the ubiquitin/proteasome system have been found to be up-regulated after spinal cord injury (De Biase et al., 2005) . Together with its possible role in the development of CNS and in the regeneration of spinal cord, scirr1 should be an interesting target for further studies.
In summary it was demonstrated 1) that scirr1 is a novel gene that encodes a 479-aa cytoplasm protein, 2) that scirr1 is expressed widely in various adult rat tissues, 3) that scirr1 is expressed mainly in neurons within the spinal cord, 4) that scirr1 is specifically expressed and developmentally regulated in CNS during early embryonic period, 5) that SCIRR1 protein is up-regulated after spinal cord injury, and 6) that SCIRR1 possibly is a FBXL protein functioning in development and regeneration of the mammalian CNS through ubiquitin/proteasome pathway.
